BioAge Labs, Inc.

BIOA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.8B · 62 employees
29
SEC Filings
$17.05
Close 2026-05-28
62
Employees

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. Our technology platform and differentiated human datasets enable us to identify promising targets based on insights into molecular changes that drive aging. In January 2025, we announced the nomination of our lead program, BGE-102, a potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor...

Latest Stock Quote

BIOA 2026-05-28 $17.05 O:$16.91 H:$17.12 L:$16.57 Vol:0.2M VWAP:$16.9137
origin leaf: b50198bb9999acebb4781cc20b6348b61b129184cc54f98deabf78421f519252

Next Earnings

Q2 FY2026 — expected 2026-08-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-242025-12-310001193125-26-120873EDGAR94K words
2025-03-202024-12-310000950170-25-042759EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-270012EDGAR67K words
2025-08-062025-06-300000950170-25-104176EDGAR—
2025-05-062025-03-310000950170-25-064552EDGAR—
2024-11-072024-09-300000950170-24-123445EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001193125-26-120864EDGAR3K words
2026-01-220001193125-26-019536EDGAR—
2026-01-200001193125-26-016046EDGAR—
2026-01-120001193125-26-009911EDGAR—
2025-12-040001193125-25-307541EDGAR—
2025-11-060001193125-25-269986EDGAR—
2025-08-060000950170-25-104151EDGAR—
2025-06-090000950170-25-083746EDGAR—
2025-06-040000950170-25-081409EDGAR—
2025-05-060000950170-25-064547EDGAR—

29 total filings indexed. 13 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001709941
TickerBIOA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.bioagelabs.com
Listed2024-09-26

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d1918145f1eb6b0959a2c121e8446146c1efb46aeef08379ee364412ba0821be
parent: 371ddf72cb2553fa9a142997e88a925d495159b1364931f8582af00ee4e01d81
content hash: 3667e0557eea0f3cebe7f903f530b75fa1b41673e5c7e8d397b58dac7119dab8
signed: 2026-06-03T12:00:25.033Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf